Independent & reader-supported — every article medically reviewed

SARMs / Myostatin inhibitors

Bimagrumab BYM338

An antibody drug that blocks a muscle-limiting signal in the body, encouraging muscle growth. Human trials in older adults and people with obesity show it builds muscle, and when paired with a weight-loss drug it helped people lose fat while keeping more muscle, though it's still not an approved medication.

Also known as BYM-338